Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease
Michihiro Iwaki, Takaomi Kessoku, Anna Ozaki, et al.
Journal of Gastroenterology and Hepatology (2021) Vol. 36, Iss. 8, pp. 2275-2284
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis
Ansel Shao Pin Tang, Cheng Han Ng, Poh Hui Phang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 7, pp. 1750-1760.e12
Closed Access | Times Cited: 72
The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 640-640
Open Access | Times Cited: 41
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease
Emmanouil Nychas, Andrea Marfil-Sánchez, Xiuqiang Chen, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Current Options and Future Directions for NAFLD and NASH Treatment
Chunye Zhang, Ming Yang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7571-7571
Open Access | Times Cited: 73
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Mohammad Shafi Kuchay, José Ignacio Martínez‐Montoro, Narendra S. Choudhary, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1346-1346
Open Access | Times Cited: 72
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Piero Portincasa, Mohamad Khalil, Annarita Graziani, et al.
European Journal of Internal Medicine (2023) Vol. 119, pp. 13-30
Closed Access | Times Cited: 25
Diet-Related Changes of Short-Chain Fatty Acids in Blood and Feces in Obesity and Metabolic Syndrome
Tamás Ilyés, Ciprian Silaghi, Alexandra Crăciun
Biology (2022) Vol. 11, Iss. 11, pp. 1556-1556
Open Access | Times Cited: 30
The role of microbiota in nonalcoholic fatty liver disease
Agostino Di Ciaula, Leonilde Bonfrate, Piero Portincasa
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 7
Closed Access | Times Cited: 29
Composition of gut microbiota and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Xin Su, Shiyun Chen, Jiazi Liu, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Closed Access | Times Cited: 16
Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index
Natthaya Chuaypen, Aisawan Asumpinawong, Pattarose Sawangsri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1807-1807
Open Access | Times Cited: 6
Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Josefin Soppert, Elisa Brandt, N Heussen, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 11, pp. 2746-2758
Open Access | Times Cited: 23
Soluble dietary fiber from Dendrocalamus brandisii (Munro) Kurz shoot improves liver injury by regulating gut microbial disorder in mice
Yufan Dong, Yuhong Guo, Qin Li, et al.
Food Chemistry X (2024) Vol. 22, pp. 101472-101472
Open Access | Times Cited: 4
Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
Yongbo Kang, Xing Kang, Hongfang Zhang, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110162-175909142110162
Open Access | Times Cited: 29
Factors Associated with Liver Fibrosis in Chinese Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
Yu Luo, Cuiyu Wang, Tian Zhang, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 293-302
Open Access | Times Cited: 10
Effects of dietary supplementation of fish oil plus vitamin D3 on gut microbiota and fecal metabolites, and their correlation with nonalcoholic fatty liver disease risk factors: a randomized controlled trial
Xueqi Li, Pan Chi, Wenjun Ma, et al.
Food & Function (2024) Vol. 15, Iss. 5, pp. 2616-2627
Closed Access | Times Cited: 3
Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study
Fangyuan Cong, Luying Zhu, Lihua Deng, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis
Miwa Kawanaka, Ken Nishino, Mayuko Kawada, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression
Chao Yang, Jiale Wu, Ligang Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet
Sai Wang, Xinyu Li, Hong‐Fang Ji, et al.
Life Sciences (2022) Vol. 310, pp. 121110-121110
Closed Access | Times Cited: 13
Amelioration of Non-Alcoholic Steatohepatitis by Atractylodes macrocephala Polysaccharide, Chlorogenic Acid, and Geniposide Combination Is Associated With Reducing Endotoxin Gut Leakage
Jing Leng, Huajie Tian, Yi Fang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 12
The Role of the Gastrointestinal Microbiome in Liver Disease
Nicholas Shalaby, Dorit Samocha‐Bonet, Nadeem O. Kaakoush, et al.
Pathogens (2023) Vol. 12, Iss. 9, pp. 1087-1087
Open Access | Times Cited: 6
Invited review: Camel milk and gut health—Understanding digestibility and the effect on gut microbiota
Abdelmoneim H. Ali, Siqi Li, Shao‐Quan Liu, et al.
Journal of Dairy Science (2023) Vol. 107, Iss. 5, pp. 2573-2585
Open Access | Times Cited: 5
Oral matrine alleviates CCl4-induced liver fibrosis via preserved HSP72 from modulated gut microbiota
J. Zhu, Bing Li, Weiming Fang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117262-117262
Closed Access | Times Cited: 1
Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications
Gong-Jing Guo, Fei Yao, Wei-Peng Lu, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 7, pp. 867-882
Open Access | Times Cited: 4
Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Sara Abdollahiyan, Ali Nabavi-Rad, Shahrbanoo Keshavarz Azizi Raftar, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top